Holen Sie sich die Stockscreener-App
42.84
0.46%
-0.20
Schlusskurs vom Vortag:
$43.04
Offen:
$43
24-Stunden-Volumen:
358.28K
Relative Volume:
0.88
Marktkapitalisierung:
$1.25B
Einnahmen:
$219.79M
Nettoeinkommen (Verlust:
$-57.47M
KGV:
-19.93
EPS:
-2.15
Netto-Cashflow:
$-19.25M
1W Leistung:
+4.85%
1M Leistung:
+8.74%
6M Leistung:
+166.58%
1J Leistung:
+60.75%
1-Tages-Spanne:
$42.39
$43.24
1-Wochen-Bereich:
$40.33
$44.28
52-Wochen-Spanne:
$14.59
$44.28
Castle Biosciences Inc Stock (CSTL) Company Profile
Firmenname
Castle Biosciences Inc
Sektor
Branche
Telefon
866-788-9007
Adresse
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Vergleichen Sie CSTL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
42.84 | 1.26B | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
623.91 | 235.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.75 | 167.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
694.75 | 55.72B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
241.04 | 40.77B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.95 | 38.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-04-30 | Eingeleitet | Lake Street | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | Bestätigt | Canaccord Genuity | Buy |
| 2019-08-19 | Eingeleitet | BTIG Research | Buy |
| 2019-08-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-08-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten
The Analyst Verdict: Castle Biosciences In The Eyes Of 7 Experts - Benzinga
Are you looking for a top momentum pick? Why Castle Biosciences, Inc. (CSTL) is a great choice - MSN
Aug Outlook: How sensitive is Castle Biosciences Inc to inflationMarket Risk Report & Entry Point Strategy Guides - baoquankhu1.vn
AIGH Capital Management LLC Acquires New Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Are You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great Choice - Yahoo Finance
Castle Biosciences, Inc. (CSTL) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings and 9.13% Upside Potential - DirectorsTalk Interviews
Castle Biosciences stock hits 52-week high at $42.25 By Investing.com - Investing.com Nigeria
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 4,017 Shares - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Hits New 12-Month HighWhat's Next? - MarketBeat
Castle Biosciences stock hits 52-week high at $42.25 - Investing.com
26,996 Shares in Castle Biosciences, Inc. $CSTL Acquired by Campbell & CO Investment Adviser LLC - MarketBeat
Risk Hedge: What are the future prospects of Castle Biosciences IncCPI Data & Daily Volume Surge Signals - baoquankhu1.vn
Insider Buy: What are the future prospects of Castle Biosciences IncQuarterly Market Review & Free Community Supported Trade Ideas - baoquankhu1.vn
Zacks.com Spotlights Perimeter Solutions, Interface, Castle Biosciences, and Great Lakes Dredge & Dock - Intellectia AI
Market Rankings: How sensitive is Castle Biosciences Inc to inflationJuly 2025 Weekly Recap & Daily Momentum Trading Reports - baoquankhu1.vn
Dividend Watch: How sensitive is Castle Biosciences Inc. to inflationAnalyst Downgrade & Weekly Return Optimization Plans - baoquankhu1.vn
Market Trends: Will Castle Biosciences Inc stock deliver better than expected guidance - Bộ Nội Vụ
Castle Biosciences (CSTL) Gets a Buy from Lake Street - The Globe and Mail
Castle Biosciences (CSTL) Sees PT Raised by Lake Street: Analyst Insights | CSTL Stock News - GuruFocus
Castle Biosciences (CSTL) Valuation After Upgraded 2025 Guidance And Strong Core Test Volume Growth - Yahoo Finance
The Bull Case For Castle Biosciences (CSTL) Could Change Following Surging Test Volumes And Raised 2025 Outlook - Yahoo Finance
Castle Biosciences (CSTL) Expects 2025 Revenue to Surpass $340 M - GuruFocus
Castle Biosciences Expects 2025 Revenue to Exceed $340 Million - Intellectia AI
Castle Biosciences 2025 total revenue expected to exceed $340 million - marketscreener.com
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results - The Manila Times
Castle Biosciences 2025 Total Revenue Expected To Exceed $340 Million - TradingView — Track All Markets
San Gabriel Valley Tribune - FinancialContent
Castle Biosciences to buy Previse - MSN
Castle Biosciences, Inc. (CSTL) Stock Analysis: Riding the Wave of Healthcare Innovation with 9.68% Upside Potential - DirectorsTalk Interviews
Can Castle Biosciences Inc. stock continue upward trendWeekly Profit Analysis & Daily Profit Maximizing Tips - Улправда
What risks investors should watch in Castle Biosciences Inc. stock2025 Support & Resistance & AI Powered Buy/Sell Recommendations - Улправда
How resilient is Castle Biosciences Inc. stock in market downturnsShare Buyback & Consistent Return Investment Signals - ulpravda.ru
Why Castle Biosciences Inc. stock is considered a top pickBull Run & Weekly High Potential Alerts - ulpravda.ru
Is Castle Biosciences Inc. stock near bottom after declineRisk Management & Reliable Breakout Forecasts - Улправда
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 1,339 Shares of Stock - MarketBeat
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 2,678 Shares of Stock - MarketBeat
Castle Biosciences Inc (FRA:086) Stock Price, Trades & News - GuruFocus
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
ทดลองเล่นสล็อต pg ไม่ เด้ง - earlytimes.in
CSTL Gears Up to Report Q4 Earnings: Here's What You Should Know - MSN
Earnings Preview: Castle Biosciences, Inc. (CSTL) Q2 Earnings Expected to Decline - MSN
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 830 Shares - MarketBeat
Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus - Yahoo Finance
Is Castle Biosciences Inc. stock vulnerable to regulatory risksHealthcare Stock Analysis & Free Professional Investment Consultations - bollywoodhelpline.com
Breakouts Watch: Why Castle Biosciences Inc. stock is considered a top pick2025 Sector Review & Real-Time Volume Triggers - moha.gov.vn
What makes Castle Biosciences (CSTL) a good fit for 'trend investing' - MSN
What Makes Castle Biosciences (CSTL) a Good Fit for 'Trend Investing' - sharewise.com
Is Castle Biosciences (NASDAQ:CSTL) Using Too Much Debt? - 富途牛牛
Castle Biosciences stock hits 52-week high at 40.66 USD - Investing.com
Castle Biosciences (NASDAQ:CSTL) Hits New 12-Month High After Analyst Upgrade - MarketBeat
Castle Biosciences stock hits 52-week high at 40.66 USD By Investing.com - Investing.com Nigeria
Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):